Biobanque. Marche_droits_trometter.pdf (Objet application/pdf) IDEAM. Astorg Partners. Strat RSE ... Dennis MAC KENNA directeur ethno pharma chez SHAMAN PHARMA. Drowning in the Magic Well: Shaman Pharmaceuticals and the Elusive Value of Traditional Knowledge -- Clapp and Crook 11 (1): 79 -- The Journal of Environment & Development. Biodiversity prospecting, and ethnobotanical search methods that draw on the medicinal knowledge of traditional societies, are mechanisms of drug discovery with the potential to reward the conservers of biological resources. Shaman Pharmaceuticals aspired to be a model of ethnobotanical bioprospecting, discovering new medicines while sharing benefits with indigenous people.
Shaman's failure to market any new pharmaceutical products and its ultimate bankruptcy were heralded as marking the failure, and future abandonment, of ethnobotanical bioprospecting. This analysis of Shaman's history suggests that risks inherent in drug development, company risk associated with Shaman's drug development strategy, and technological change in the industry all contributed to its failure. The authors examine the opportunities and constraints encountered in bioprospecting and ethnobotanical searches and argue that natural products will remain important to drug development. Shaman Pharmaceuticals: Integrating Indigenous Knowledge. Shaman Pharmaceuticals: Integrating Indigenous Knowledge, Tropical Medicinal Plants, Medicine, Modern Science and Reciprocity into a Novel Drug Discovery Approach Donald E.
Bierer, Thomas J. Carlson, and Steven R. King Shaman Pharmaceuticals, Inc. 213 East Grand Ave. South San Francisco, CA 94080 Introduction Tropical forest plant species have served as a source of medicines for people of the tropics for millennia. Today, five centuries after the Old World and the New World first collided, it is no longer a question of whether indigenous peoples should benefit from products that have been developed on the basis of their knowledge.
Shaman Pharmaceuticals, Inc. is a South San Francisco-based pharmaceutical company that focuses on isolating bioactive compounds from tropical plants that have a history of medicinal use. The Rainforest as a Source For New Pharmaceuticals Shaman Pharmaceutical's operations began in 1990. Conclusion References. Biotics Research Corporation. BOISVERT-contrats.pdf (Objet application/pdf) Bienvenue au royaume de l'or vert. • Le Brésil possède un trésor unique : sa biodiversité. L'essor des biotechnologies attire déjà la convoitise des plus grandes entreprises mondiales. Reste à élaborer une législation adéquate. Chaque matin, avant de se mettre au travail, João da Cruz Oliveira, 62 ans, agriculteur à Poconé, dans le Mato Grosso, boit cul sec sa cachaça [alcool de canne à sucre] mélangée à la racine d'une plante connue sous le nom de nó-de-cachorro [noeud de chien]. L'odeur en est forte, mais le goût n'est pas si désagréable.
Il évoque celui d'un bois odorant comme le santal. João da Cruz tient la recette de cette infusion - connue dans tout le Pantanal [la zone de marais] du Mato Grosso - de ses parents. Stratégie des entr pharma en bioprospection. BOISVERT-biopiraterie.pdf (Objet application/pdf) Débats autour de la bioprospection. SBF (Société Botanique de France) TELA BOTANICA.